The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.2043C>G (p.Cys681Trp)

CA10585743

252188 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: c12a6a0d-1d06-4705-8036-67b2e5a31e81

HGVS expressions

NM_000527.5:c.2043C>G
NM_000527.5(LDLR):c.2043C>G (p.Cys681Trp)
ENST00000558518.6:c.2043C>G
ENST00000252444.9:n.2297C>G
ENST00000455727.6:c.1539C>G
ENST00000535915.5:c.1920C>G
ENST00000545707.5:c.1606+192C>G
ENST00000557933.5:c.2043C>G
ENST00000558013.5:c.2043C>G
ENST00000558518.5:c.2043C>G
NM_000527.4:c.2043C>G
NM_001195798.1:c.2043C>G
NM_001195799.1:c.1920C>G
NM_001195800.1:c.1539C>G
NM_001195803.1:c.1606+192C>G
NM_001195798.2:c.2043C>G
NM_001195799.2:c.1920C>G
NM_001195800.2:c.1539C>G
NM_001195803.2:c.1606+192C>G
NC_000019.10:g.11120425C>G
CM000681.2:g.11120425C>G
NC_000019.9:g.11231101C>G
CM000681.1:g.11231101C>G
NC_000019.8:g.11092101C>G
NG_009060.1:g.36045C>G

Pathogenic

Met criteria codes 5
PP1_Strong PP4 PP3 PM2 PM1
Not Met criteria codes 21
PS2 PS4 PS3 PS1 PVS1 PP2 BA1 PM6 BS4 BS3 BS1 PM3 PM4 PM5 BS2 BP5 BP7 BP2 BP3 BP4 BP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
NM_000527.5(LDLR):c.2043C>G (p.Cys681Trp) variant is classified as Pathogenic for Familial Hypercholesterolemia by applying evidence codes (PP1_Strong, PM1, PM2, PP3 and PP4) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1101/2021.03.17.21252755). The supporting evidence is as follows: PP1_strong - Variant segregates with FH phenotype in 7 informative meioses in 1 family from PMID: 16092059. PM1 - Variant meets PM2 and is one of listed Cysteine. PM2 - No population data was found for this allele in gnomAD (gnomAD v2.1.1). PP3 - REVEL: 0,83. PP4 - Variant meet PM2. PMID: 16092059 - 1 case who fulfills Simon-Broome criteria for FH.
Met criteria codes
PP1_Strong
Variant segregates with FH phenotype in 7 informative meioses in 1 family from PMID: 16092059.
PP4
Variant meet PM2. PMID: 16092059 - 1 case who fulfills Simon-Broome criteria for FH.
PP3
REVEL: 0,83. Score is above 0,75.
PM2
No population data was found for this allele in gnomAD (gnomAD v2.1.1).
PM1
Variant meets PM2 and is one of listed Cysteine. S-S bond with Cys667.
Not Met criteria codes
PS2
No de novo cases were identified.
PS4
PMID: 16092059 - 1 case with Simon-Broome criteria. At least 2 unrelated cases are needed for PS4.
PS3
No functional assays performed/found - not applicable.
PS1
Variant meets PM1, so not applicable.
PVS1
Missense variant. Not applicable.
PP2
Not applicable.
BA1
No population data was found for this allele in gnomAD (gnomAD v2.1.1).
PM6
No de novo cases were identified.
BS4
No non-segregations were identified/found.
BS3
No functional assays performed/found - not applicable.
BS1
No population data was found for this allele in gnomAD (gnomAD v2.1.1).
PM3
Not identified in individuals with other variants.
PM4
Missense variant. Not applicable.
PM5
Variant meets PM1, so not applicable.
BS2
No unaffected individuals identified with the variant.
BP5
Not applicable.
BP7
Missense variant. Not applicable.
BP2
Not identified in individuals with other variants.
BP3
Not applicable.
BP4
REVEL: 0,83. Score is not below 0,50.
BP1
Not applicable.
Approved on: 2021-06-18
Published on: 2021-06-24
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.